New sedation combo could speed up endoscopy recovery
NCT ID NCT07423676
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of ketamine and dexmedetomidine (Ketodex) works faster and safer than the usual propofol-midazolam for sedation during upper GI endoscopy. Fifty-two adults aged 21–60 will be enrolled. Researchers will measure how quickly patients reach the right sedation level, how fast they recover, and any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ketamine and dexmedetomidine (Ketodex) compared to propofol and midazolam
What this could lead to
If Ketodex works better, it could offer a faster, safer sedation option for routine GI endoscopy.
What could go wrong
This is a small, early-stage trial with only 52 participants. Results may not apply to all patients, and side effects like nausea or blood pressure changes are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION DURING GI ENDOSCOPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••